The 13 healthcare companies below have had some of the most shareholder votes cast against their CEO’s pay package, according to a 2020 report from nonprofit shareholder advocacy group As You Sow. The nonprofit used voting data from Morningstar Fund Votes and compensation information to rank 100 S&P 500 companies with the most shareholder votes against CEO pay.
As You Sow notes some CEOs may no longer hold the positions listed below, as the rankings were calculated using data made available before June 30, 2019.
Here are 13 healthcare CEOs on the list:
Joseph Hogan (Align Technology): 55.3 percent of shareholders voted against his $41.8 million pay
Bryan Hanson (Zimmer Biomet): 37.6 percent of shareholders voted against his $9.7 million pay
Stephen MacMillan (Hologic): 34.4 percent of shareholders voted against his $42 million pay
Alex Gorsky (Johnson & Johnson): 34 percent of shareholders voted against his $20.1 million pay
Leonard Schleifer, MD, PhD (Regeneron Pharmaceuticals): 32.9 percent of shareholders voted against his $26.5 million pay
Herve Hoppenot (Incyte): 30.8 percent of shareholders voted against his $9.3 million pay
Michael Neidorff (Centene): 27.1 percent of shareholders voted against his $26.1 million pay
Ludwig Hantson (Alexion Pharmaceuticals): 15.8 percent of shareholders voted against his $16.5 million pay
Marc Casper (Thermo Fisher Scientific): 13.8 percent of shareholders voted against his $18.6 million pay
Brenton Saunders (Allergan): 13.4 percent of shareholders voted against his $6.6 million pay
John Hammergren (McKesson): 13.3 percent of shareholders voted against his $18.1 million pay
Ari Bousbib (IQVIA): 11.9 percent of shareholders voted against his $16.5 million pay
Heather Bresch (Mylan): 11.4 percent of shareholders voted against her $13.3 million pay
Access the full list here.
More articles on compensation:
16 ‘overpaid’ healthcare CEOs
No pay raise for CHS CEO in 2020
ER physicians to take 4% pay cut amid UnitedHealthcare-TeamHealth dispute
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
